3/A

FORM 3/A SUBMISSION

Company: Kalaris Therapeutics, Inc.
Filed: October 14, 2020
Period of Report: July 29, 2020
Accession Number: 0000899243-20-028184

View Document ↗ View on SEC.gov ↗